References
- Peyvandi F, Mannucci PM, Lak M, et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102: 626-628. doi: 10.1046/j.1365-2141.1998.00806.x.
- Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125: 2052-2061. doi: 10.1182/blood-2014-08-532820.
- Al-Mouqdad M, Abdelrahim A, Kahlon BMM, Almahmoud L, Asfour S. A successful treatment of infant who had two significant intracranial hemorrhage with factor X replacement: case report. Neonat Pediatr Med 2018; 4: 163. doi: 10.4172/2572-4983.1000163.
- Escobar MA. Advances in the treatment of inherited coagulation disorders. Haemophilia 2013; 19: 648-659. doi: 10.1111/hae.12137.
- Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009; 35: 407-415. doi: 10.1055/s-0029-1225763.
- Powell JS, Rodgers GM. Inherited coagulation disorders. In: Greer JP, Arber DA, Glader B, et al. (eds.). Wintrobe’s Clinical Hematology. 13th edn. 2014. Philadelphia: Lippincott Williams & Wilkins.1143-1185.
- World Federation of Hemophilia. Report on the Annual Global Survey 2021. October 2022. Available from https://www1.wfh.org/publications/files/pdf-2324.pdf (accessed 10 June 2023).
- Shah NM, Patel AP. An analysis of 8 cases of factor X deficiency. Indian J Hematol Blood Transfus 2008; 24 (1): 23-25. doi: 10.1007/s12288-008-0018-7.
- Sinha S, Barik S. Factor X deficiency: a rare case of inherited coagulation disorder presenting as hemarthrosis. Int J Med Res Rev 2014; 2(3): 253-255. doi:10.17511/ijmrr.2014.i03.14.
- Chatterjee T, Philip J, Nair V, et al. Inherited factor X (Stuart-Prower factor) deficiency and its management. Med J Armed Forces India 2015; 71 (suppl 1): S184-S186. doi: 10.1016/j. mjafi.2014.01.007.
- Peyvandi F, Auerswald G, Austin SK, et al. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Rev 2021; 50: 100833. doi: 10.1016/j.blre.2021.100833.
- Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 304-26. doi: 10.1111/bjh.13058.
- Turecek PL, Váradi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004; 10 Suppl 2: 3-9. doi: 10.1111/j.1365-2516.2004.00934.x.
- Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 2004; 10: 593-628. doi: 10.1111/j.1365-2516.2004.00944.x.
- Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10: 615-21. doi: 10.1111/j.1538-7836.2012.04653.x.
- Peyvandi F, Di Michele D, Bolton-Maggs PH, et al. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012; 10: 1938-43. doi: 10.1111/j.1538-7836.2012.04844.x.
- Shinohara K, Adachi M, Matsui K, et al. A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu. Int J Hematol 2008; 87(3): 256-259. doi: 10.1007/s12185-008-0035-1.
- Peyvandi F, Menegatti M, Santagostino E, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002; 117: 685-692. doi: 10.1046/j.1365-2141.2002.03486.x.
- Telfer TP, Denson KW, Wright DR. A ‘new’ coagulation defect. Br J Haematol 1956; 2(3): 308-316. doi: 10.1111/j.1365-2141-1956.tb06703.x.
- Hougie C, Barrow EM, Graham JB. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957; 36: 485-496. doi: 10.1172/JCI103446.
- Redely SV, Zhou ZQ, Rao KJ, Scott JP, Watzke H, High KA, Jagadeeswaran P. Molecular characterization of human factor XSan.Antonio. Blood 1989; 74(5): 1486-90. doi: 10.1182/blood. V74.5.1486.1486.
- James HL, Girolami A, Fair DS. Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. Blood 1991; 77: 317-323. doi: 10.1182/blood.V77.2.317.317.
- Ermis B, Ors R, Tastekin A, Orhan F. Severe congenital factor X deficiency with intracranial bleeding in two siblings. Brain Dev 2004; 6: 137-138. doi: 10.1016/S0387-7604(03)00119-0.
- Sandler E, Gross S. Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant. Am J Pediatr Hematol Oncol 1992; 14: 163-165. doi: 10.1097/00043426-199205000-00012.
- el Kalla S, Menon NS. Neonatal congenital factor X deficiency. Pediatr Hematol Oncol 1991; 8: 347-354. doi: 10.3109/08880019109028808.
- Shim YJ, Won DI. Pharmacokinetics and prophylactic use of FEIBA ® in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report. Haemophilia 2013; 19(6): e364–7. doi: 10.1111/hae.12245.